USPSTF finalizes recommendations on initiating aspirin for primary CVD prevention

The U.S. Preventive Services Task Force has published a final recommendation that advises against the initiation of low-dose aspirin for primary CVD prevention in adults aged 60 years or older, a D-grade recommendation.
The task force also issued a C-grade recommendation that states low-dose aspirin for primary CVD prevention should be considered on a case-by-case basis in adults aged 40 to 59 years with a 10% or greater 10-year CVD risk.
These recommendations align with the USPSTF’s draft recommendations that were released in October 2021. They are an update to the task force’s

The U.S. Preventive Services Task Force has published a final recommendation that advises against the initiation of low-dose aspirin for primary CVD prevention in adults aged 60 years or older, a D-grade recommendation.
The task force also issued a C-grade recommendation that states low-dose aspirin for primary CVD prevention should be considered on a case-by-case basis in adults aged 40 to 59 years with a 10% or greater 10-year CVD risk.
These recommendations align with the USPSTF’s draft recommendations that were released in October 2021. They are an update to the task force’s